A detailed history of Gw&K Investment Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 59,713 shares of CRL stock, worth $11.1 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
59,713
Previous 58,662 1.79%
Holding current value
$11.1 Million
Previous $12.1 Million 2.94%
% of portfolio
0.1%
Previous 0.11%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$187.96 - $245.29 $197,545 - $257,799
1,051 Added 1.79%
59,713 $11.8 Million
Q2 2024

Aug 12, 2024

BUY
$206.39 - $268.73 $825,766 - $1.08 Million
4,001 Added 7.32%
58,662 $12.1 Million
Q1 2024

May 08, 2024

SELL
$203.52 - $273.43 $172,788 - $232,142
-849 Reduced 1.53%
54,661 $14.8 Million
Q4 2023

Feb 09, 2024

BUY
$164.52 - $238.84 $1.61 Million - $2.34 Million
9,782 Added 21.39%
55,510 $13.1 Million
Q3 2023

Nov 09, 2023

BUY
$194.44 - $217.61 $3.26 Million - $3.65 Million
16,790 Added 58.02%
45,728 $8.96 Million
Q2 2023

Aug 09, 2023

BUY
$183.71 - $210.25 $183,710 - $210,250
1,000 Added 3.58%
28,938 $6.08 Million
Q1 2023

May 09, 2023

BUY
$191.89 - $259.92 $718,436 - $973,140
3,744 Added 15.47%
27,938 $5.64 Million
Q4 2022

Feb 10, 2023

BUY
$197.11 - $250.07 $2.73 Million - $3.46 Million
13,852 Added 133.94%
24,194 $5.27 Million
Q3 2022

Nov 09, 2022

SELL
$182.44 - $250.54 $89,213 - $122,514
-489 Reduced 4.51%
10,342 $2.04 Million
Q2 2022

Aug 09, 2022

SELL
$204.13 - $302.4 $101,044 - $149,688
-495 Reduced 4.37%
10,831 $2.32 Million
Q1 2022

May 09, 2022

SELL
$255.51 - $362.11 $67,965 - $96,321
-266 Reduced 2.29%
11,326 $3.22 Million
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $1.3 Million - $1.66 Million
-3,710 Reduced 24.25%
11,592 $4.37 Million
Q3 2021

Nov 10, 2021

SELL
$372.64 - $458.3 $27,948 - $34,372
-75 Reduced 0.49%
15,302 $6.32 Million
Q2 2021

Aug 10, 2021

SELL
$294.17 - $371.65 $2.63 Million - $3.32 Million
-8,925 Reduced 36.73%
15,377 $5.69 Million
Q1 2021

May 11, 2021

SELL
$249.67 - $299.48 $927,524 - $1.11 Million
-3,715 Reduced 13.26%
24,302 $7.04 Million
Q4 2020

Feb 05, 2021

SELL
$222.0 - $252.62 $2.36 Million - $2.68 Million
-10,620 Reduced 27.49%
28,017 $7 Million
Q3 2020

Nov 10, 2020

SELL
$175.56 - $226.45 $359,898 - $464,222
-2,050 Reduced 5.04%
38,637 $8.75 Million
Q2 2020

Aug 06, 2020

BUY
$118.84 - $189.72 $332,752 - $531,216
2,800 Added 7.39%
40,687 $7.09 Million
Q1 2020

May 11, 2020

SELL
$98.9 - $178.34 $793,672 - $1.43 Million
-8,025 Reduced 17.48%
37,887 $4.78 Million
Q4 2019

Feb 10, 2020

SELL
$126.05 - $152.76 $381,931 - $462,862
-3,030 Reduced 6.19%
45,912 $7.01 Million
Q3 2019

Nov 05, 2019

SELL
$125.07 - $143.67 $323,305 - $371,386
-2,585 Reduced 5.02%
48,942 $6.48 Million
Q2 2019

Aug 06, 2019

BUY
$123.4 - $148.55 $6.36 Million - $7.65 Million
51,527 New
51,527 $7.31 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.48B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Gw&K Investment Management, LLC Portfolio

Follow Gw&K Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.